Blog
RSS FeedPosted by Michael Wonder on 18 Apr 2016
'She's coming after the rest of you'
17 April 2016 - Partner writes angry letter to the cancer killing the love of his life. ...
Posted by Michael Wonder on 12 Apr 2016
Proposal to list bedaquiline fumarate (Sirturo) and siltuximab (Sylvant) for rare disorders
12 April 2016 - PHARMAC is seeking feedback on a proposal to list bedaquiline fumarate (Sirturo) and siltuximab (Sylvant) resulting from ...
Posted by Michael Wonder on 12 Apr 2016
PHARMAC notification of decision to fund cinacalcet hydrochloride (Sensipar) for parathyroid carcinoma and calciphylaxis
12 April 2016 - PHARMAC is pleased to announce a decision to list cinacalcet hydrochloride (Sensipar) on the Pharmaceutical Schedule through ...
Posted by Michael Wonder on 11 Apr 2016
New Zealand patients call for cannabis
11 April 2016 - A Northland family believe a lack of funding for medicinal marijuana is preventing people from applying ...
Posted by Michael Wonder on 08 Apr 2016
New Zealand’s medicines landscape
8 April 2016 - Medicines New Zealand believes New Zealanders deserve better access to medicines when they need them. ...
Posted by Michael Wonder on 31 Mar 2016
New Zealand Pharmaceutical Schedule - 1 April 2016 update
1 April 2016 - The April 2016 update to the New Zealand Pharmaceutical Schedule notes the listing of many new ...
Posted by Michael Wonder on 30 Mar 2016
Kiwi mum petitions for free sunscreen as NZ overtakes Australia's melanoma rate
31 March 2016 - A Kiwi mother is petitioning the Government to provide free sunscreen for all children, after it was ...
Posted by Michael Wonder on 21 Mar 2016
Call for NZ Government to fund HPV vaccine for boys
20 March 2016 - Throat-cancer patient Grant Munro paid for his son to be vaccinated against the sexually-transmitted HPV virus because ...
Posted by Michael Wonder on 17 Mar 2016
Decision to list galsulfase (Naglazyme) for mucopolysaccharidosis (MPS) VI
17 March 2016 - PHARMAC is pleased to announce the approval of an agreement with BioMarin Pharmaceutical Australia Pty Ltd to ...
Posted by Michael Wonder on 16 Mar 2016
RFP - supply of bortezomib
16 March 2016 - PHARMAC invites proposals for the supply of bortezomib in New Zealand. ...
Posted by Michael Wonder on 11 Mar 2016
Proposal to list cinacalcet (Sensipar) on the Pharmaceutical Schedule for parathyroid carcinoma and calciphylaxis
11 March 2016 - PHARMAC is seeking feedback on a proposal to list cinacalcet (Sensipar) on the Pharmaceutical Schedule through a ...
Posted by Michael Wonder on 09 Mar 2016
Supply of gonadotropin-releasing hormone analogues
9 March 2016 - PHARMAC invites proposals for the supply of gonadotropin-releasing hormone analogues in New Zealand. ...
Posted by Michael Wonder on 07 Mar 2016
'Real, urgent' plight for melanoma patients hoping for better Keytruda funding
7 March 2016 - Pharmac's assignment of a low-funding priority to pembrolizumab (Keytruda) for advanced melanoma has brought cancer drug funding ...
Posted by Michael Wonder on 06 Mar 2016
Drug spend a hard pill to swallow
6 March 2016 - If my child was dying of a disease and there was a drug that could help her ...
Posted by Michael Wonder on 06 Mar 2016
Melanoma drug Keytruda should be funded in NZ, Labour says
6 March 2016 - The melanoma drug Keytruda should be funded here, Labour says -- despite the head of PHARMAC saying ...